[1] 蔡可可,鄢阳,耿江,等. WBC、NLR与上尿路尿路上皮癌分期及分级的相关性分析[J].医学临床研究,2018,35(7):1366-1368. [2] 袁道彰,徐晓龙,都兴华,等.全腹腔镜肾输尿管全长切除术治疗输尿管中下段尿路上皮细胞癌36例报道[J].中国现代医学杂志,2017,27(10):141-144. [3] Aoun F,Kourie HR,Sirtaine N,et al.Disappearance of upper urinary tract urothelial carcinoma after treatment of a borderline brenner tumor:case report and literature review[J].Oncol Res Treat,2015,38(7/8):379-381. [4] 任玉嫄,王功伟,沈丹华,等.215例尿道病变患者年龄、性别及部位初步分析[J].现代肿瘤医学,2015,23(9):1265-1267. [5] Kuroda K,Asakuma J,Asano T,et al.Clinical significance of p21-activated kinase 1 expression level in patients with upper urinary tract urothelial carcinoma[J].Jap J Clin Oncol,2015,45(1):103-110. [6] 方冬,黄吉炜,鲍一歌,等.中国上尿路尿路上皮癌人群特征和地区差异:基于CUDA-UTUC协作组的多中心研究[J].中华泌尿外科杂志,2017,38(12):885-890. [7] 王跃,贺慧颖.上尿路尿路上皮癌368例根治标本的临床病理特点及预后分析[J].中华病理学杂志,2016,45(10):681-686. [8] 臧立,霍彬,王磊,等.培美曲赛联合奈达铂对一线化疗失败的晚期尿路上皮癌的有效性及安全性分析[J].中华泌尿外科杂志,2017,38(12):910-913. [9] 彭金玲,边育红,王丽,等.马兜铃酸肾毒性的研究进展[J].环球中医药,2013,6(1):60-64. [10] Sun MJ,Sun R,Chen LJ, et al.The therapeutic efficiency of extracorporeal magnetic innervation treatment in women with urinary tract dysfunction following radical hysterectomy[J].J Obstet Gynaecol,2015,35(1):74-78.
2019, Vol. 36 
